Rational monoclonal antibody development to emerging pathogens, biothreat agents and agents of foreign animal disease: The antigen scale (Q33222541)

24 July 2017

1 reference

title

Rational monoclonal antibody development to emerging pathogens, biothreat agents and agents of foreign animal disease: The antigen scale (English)

1 reference

24 July 2017

1 reference

1 reference

1 reference

1 reference

Jody D Berry

1

1 reference

24 July 2017

1 September 2005

1 reference

24 July 2017

The Veterinary Journal

1 reference

24 July 2017

170

1 reference

24 July 2017

2

1 reference

24 July 2017

193-211

1 reference

Neutralizing cross-reactive and non-neutralizing monoclonal antibodies to HIV-1 gp120.

24 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Effect of cationization on anti-hapten antibody responses in sheep and mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Immunoassay of infectious agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

A novel strategy for generating monoclonal antibodies from single, isolated lymphocytes producing antibodies of defined specificities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Recombinant human Fab fragments neutralize human type 1 immunodeficiency virus in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Human monoclonal Fab fragments derived from a combinatorial library bind to respiratory syncytial virus F glycoprotein and neutralize infectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Molecular profile of an antibody response to HIV-1 as probed by combinatorial libraries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Monoclonal antibodies, against O1 serotype foot-and-mouth disease virus, from a natural bovine host, recognize similar antigenic features to those defined by the mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Effect of the elapsed time after the final antigen boost on the specificity of monoclonal antibodies produced by B cell hybridomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

The dynamic nature of the antibody repertoire

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Rapid Monoclonal Antibody Generation Via Dendritic Cell TargetingIn Vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Development of functional human monoclonal single-chain variable fragment antibody against HIV-1 from human cervical B cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Development and characterisation of neutralising monoclonal antibody to the SARS-coronavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Functional human monoclonal antibodies of all isotypes constructed from phage display library-derived single-chain Fv antibody fragments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Mouse/human chimeric monoclonal antibody in man: kinetics and immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Distinct mechanisms of neutralization by monoclonal antibodies specific for sites in the N-terminal or C-terminal domain of murine leukemia virus SU

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Neutralization antigenic sites on type Asia-1 foot-and-mouth disease virus defined by monoclonal antibody-resistant variants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Influenza virus hemagglutinin-specific antibodies isolated from a combinatorial expression library are closely related to the immune response of the donor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Making antibody fragments using phage display libraries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Peptides on phage: a vast library of peptides for identifying ligands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Rapid cloning of any rearranged mouse immunoglobulin variable genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

A simple, single-step technique for selecting and cloning hybridomas for the production of monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Recombinant single-chain variable fragment antibodies directed against Clostridium difficile toxin B produced by use of an optimized phage display system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Random peptide libraries: a source of specific protein binding molecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Antibody arrays for high-throughput screening of antibody-antigen interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Isolation of single-chain antibody fragments against Venezuelan equine encephalomyelitis virus from two different immune sources

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Production of monoclonal antibodies: strategy and tactics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

The evaluation of limiting dilution assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Epitope masking and immunodominance--complications in the selection of monoclonal antibodies against HCG.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Construction of murine phage antibody library and selection of ricin-specific single-chain antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Antibody engineering at the millennium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Specific amplification of rearranged immunoglobulin variable region genes from mouse hybridoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Original and artificial antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Characterization of a macaque recombinant monoclonal antibody that binds to a CD4-induced epitope and neutralizes simian immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

The use of tolerization in the production of monoclonal antibodies against minor antigenic determinants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Production of an ovine monoclonal antibody to testosterone by an interspecies fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Preparation of a bovine monoclonal antibody to testosterone by interspecies fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

A bovine monoclonal antibody to oestrone/oestradiol prepared by a (murine x bovine) xbovine interspecies fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Veterinary sources of nonrodent monoclonal antibodies: interspecific and intraspecific hybridomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Antigenic competition in the immune response against protein mixtures: strain-specific non-immunogenicity of Escherichia coli antigens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Isolation and expression of recombinant antibody fragments to the biological warfare pathogen Brucella melitensis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Electron microscopy for rapid diagnosis of infectious agents in emergent situations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

In vitro selection and evolution of functional proteins by using ribosome display

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Antibody-ribosome-mRNA (ARM) complexes as efficient selection particles for in vitro display and evolution of antibody combining sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

A Mab to a unique cerebellar neuron generated by immunosuppression and rapid immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Evolution of immunoglobulin genes: VH families in the amphibian Xenopus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Production of human monoclonal and polyclonal antibodies in TransChromo animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Production of fully human antibodies by transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Enhancement of alpha -helicity in the HIV-1 inhibitory peptide DP178 leads to an increased affinity for human monoclonal antibody 2F5 but does not elicit neutralizing responses in vitro. Implications for vaccine design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Identification of two neutralizing and 8 non-neutralizing epitopes on simian immunodeficiency virus envelope using monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Isolation of tumor cell-specific single-chain Fv from immunized mice using phage-antibody libraries and the re-construction of whole antibodies from these antibody fragments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Rapid correlation between field isolates and vaccine strains of foot-and-mouth disease virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Mouse variable-region gene families: complexity, polymorphism and use in non-autoimmune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Continuous cultures of fused cells secreting antibody of predefined specificity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Reliable cloning of functional antibody variable domains from hybridomas and spleen cell repertoires employing a reengineered phage display system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

A modified method to induce immune polyclonal ascites fluid in BALB/c mice using Sp2/0-Ag14 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Rapid cloning of rearranged immunoglobulin genes from human hybridoma cells using mixed primers and the polymerase chain reaction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Tolerization of adult mice to immunodominant proteins before monoclonal antibody production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

. . . and such are little lymphocytes made of

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Immunoprophylaxis in fish by injection of mouse antibody genes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Phage antibodies: filamentous phage displaying antibody variable domains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Analyzing antibody specificity with whole proteome microarrays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Human monoclonal Fab fragments specific for viral antigens from combinatorial IgA libraries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Acute and long-term effects of booster immunisation on frequencies of antigen-specific memory B-lymphocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Phage display of recombinant antibodies toward Burkholderia pseudomallei exotoxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Generation of native bovine mAbs by phage display

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Characteristics of human antibody repertoires following active immune responses in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Antibody-selectable filamentous fd phage vectors: affinity purification of target genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Clinical laboratory applications of monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Rabbit immune repertoires as sources for therapeutic monoclonal antibodies: the impact of kappa allotype-correlated variation in cysteine content on antibody libraries selected by phage display

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

A phage display approach for rapid antibody humanization: designed combinatorial V gene libraries.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Antibody libraries in drug and target discovery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Mouse monoclonal antibodies to human immunodeficiency virus glycoprotein 120 generated by repeated immunization with glycoprotein 120 from a single isolate, or by sequential immunization with glycoprotein 120 from three isolates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Identification by phage display and characterization of two neutralizing chimpanzee monoclonal antibodies to the hepatitis E virus capsid protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Four chimpanzee monoclonal antibodies isolated by phage display neutralize hepatitis a virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Searching for Peptide Ligands with an Epitope Library

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

PCR strategies for isolation of the 5' end of an immunoglobulin-encoding bovine cDNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

The immune diversity in a test tube--non-immunised antibody libraries and functional variability in defined protein scaffolds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Rabbit monoclonal antibodies: generating a fusion partner to produce rabbit-rabbit hybridomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

The identification of monoclonal class switch variants by sib selection and an ELISA assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Construction of a combinatorial IgE library from an allergic patient. Isolation and characterization of human IgE Fabs with specificity for the major timothy grass pollen allergen, Phl p 5.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Synthetic peptides corresponding to the F protein of RSV stimulate murine B and T cells but fail to confer protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Human antibodies as next generation therapeutics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Characterization of human class-switched polymeric (immunoglobulin M [IgM] and IgA) anti-human immunodeficiency virus type 1 antibodies 2F5 and 2G12.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Regulation of tryptophan synthase gene expression in Chlamydia trachomatis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Developments in international standardization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Evaluation of different lymphoid tissue sources for the construction of human immunoglobulin gene libraries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

DNA vaccination with the major outer-membrane protein gene induces acquired immunity to Chlamydia trachomatis (mouse pneumonitis) infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

Human antibodies from combinatorial libraries.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

7 January 2021

inferred from DOI database lookup

Antibody recognition of a neutralization epitope on the major outer membrane protein of Chlamydia trachomatis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.04.021

7 January 2021

inferred from DOI database lookup

Bovine IgG repertoire is dominated by a single diversified VH gene family.

1 reference

12 December 2020

Cloning immunoglobulin variable domains for expression by the polymerase chain reaction. 1989

1 reference

12 December 2020

Potential of primate monoclonal antibodies to substitute for human antibodies: nucleotide sequence of chimpanzee Fab fragments.

1 reference

12 December 2020

Refocusing neutralizing antibody response by targeted dampening of an immunodominant epitope.

1 reference

12 December 2020

Relationship between three different B cell types and the specific efficiency of hybridoma formation

1 reference

12 December 2020

Production of monoclonal antibodies by genetic immunization

1 reference

12 December 2020

The sheep Ig variable region repertoire consists of a single VH family.

1 reference

12 December 2020

Regulation of IgM and IgD synthesis in B lymphocytes. I. Changes in biosynthesis of mRNA for mu- and delta-chains

1 reference

12 December 2020

Subtractive immunization techniques for the production of monoclonal antibodies to rare antigens

1 reference

12 December 2020

Simian immunodeficiency virus (SIV) envelope-specific Fabs with high-level homologous neutralizing activity: recovery from a long-term-nonprogressor SIV-infected macaque

1 reference

12 December 2020

Neutralizing murine monoclonal antibodies to human IL-5 isolated from hybridomas and a filamentous phage Fab display library

1 reference

12 December 2020

Neutralizing recombinant human antibodies to a conformational V2- and CD4-binding site-sensitive epitope of HIV-1 gp120 isolated by using an epitope-masking procedure.

1 reference

12 December 2020

How many specific B cells are needed to protect against a virus?

1 reference

12 December 2020

Dynamics of B cell repertoire formation: normal patterns of clonal turnover are altered by ligand interaction.

1 reference

12 December 2020

10.1016/J.TVJL.2004.04.021

Identifiers

DOI

1 reference

24 July 2017

1 reference

PubMed ID

16129340